Form D Explorer
ELIXIRGEN THERAPEUTICS, INC. · CIK 1744333

Report a data issueCitable research briefCompare issuerPrivate research collection

ELIXIRGEN THERAPEUTICS, INC.

CIK 1744333 · Corporation · Inc. DELAWARE · BALTIMORE, Maryland · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

The reported offering amount was $3,600,000 in the Apr 9, 2025 filing and $4,000,000 in the Nov 13, 2025 filing. The two records may concern different offerings. All 3 stored filings from Feb 12, 2025 to Nov 13, 2025 are original notices.

Filings
3
Original notices
3
Amendments
0
Activity
Feb 12, 2025
through Nov 13, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldApr 9, 2025 · DNov 13, 2025 · DLater minus earlier
Reported offering amount$3,600,000$4,000,000$400,000
Reported amount sold$3,600,000$4,000,000$400,000
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001744333-25-000002 · Later SEC source: 0001744333-25-000004

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Nov 13, 2025

Reported offering amount
$4,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$4,000,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (3)